Stocks Explorer
Stocks
Sectors
Search
Eisai Co Ltd(ESALF) News
Profile
Chart
News
Analysis
ESALF price today
by TradingView
Date
Title
Mar 31
Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA
‹ Prev
Page
of 1
Next ›